06.06.2014 • NewsBASFDede WillamsEllba

Explosion at Shell-BASF Moerdijk Plant Injures Two

Two workers suffered minor burns, and ethylbenzene was released into the atmosphere following two explosions at the Moerdijk chemical complex in the Netherlands late on June 3.

Shell, which operates the styrene monomer and propylene oxide plant (SM/PO) for Ellba, the 50:50 joint venture with BASF, said concentrations of the chemical were too small to pose a threat to nearby neighborhoods. The site is 40 km southeast of Rotterdam.

Firefighters worked into the early morning hours to fight the blaze that broke out in a reactor undergoing maintenance.

Shell said an investigation was under way and that the extent of damage had not yet been calculated. Production in the rest of the complex was proceeding normally, it added.

The plant has capacity for 550,000 t/y of SM and 250,000 t/y of PO. Market reports said demand for the products spiked overnight.

The joint venture was expected to declare force majeure but had not yet done so at press time.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.